Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib
接受索拉非尼治疗的晚期非小细胞肺癌患者的 KRAS 突变、血管生成生物标志物和 DCE-MRI 评估
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-10-2331
Ronan J Kelly, Arun Rajan, Jeremy Force, Ariel Lopez-Chavez, Corrine Keen, Liang Cao, Yunkai Yu, Peter Choyke, Baris Turkbey, Mark Raffeld, Liqiang Xi, Seth M Steinberg, John J Wright, Shivaani Kummar, Martin Gutierrez, Giuseppe Giaccone
免疫
细胞生物学
肺癌
肿瘤细胞
Angiogenesis